Science Weekly cover image

Will new treatments change the way we view cancer for good?

Science Weekly

00:00

The Benefits of Targeted Therapy for Lung Cancer

This is the first time that one of these oral what we call targeted therapies has been used in this early setting and it's improved survival. There was a 51% decrease in death with this pill versus the placebo. Only about 15 to 50 percent depending where you live have this abnormality so we're plucking off a good chunk but there's still a lot of work to do to get the other patients we are working on.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app